GlaxoSmithKline documents show autism from vaccines Revealed in Italian lawsuit, impossible in US
An Italian court recently awarded damages to a boy who developed autism as an injury from the GlaxoSmithKline's Infanrix Hexa vaccine, a combined vaccine for polio, diphtheria, tetanus, hepatitis B, pertussis and Haemophilus influenza type B. A key component of the trial was internal GlaxoSmithKline documents that revealed at least five acknowledged cases of autism resulting from Infanrix Hexa among the children enrolled in the trials for the shot. These documents were revealed during the trial through the discovery process, a basic legal right in civil suits in which the plaintiff and defendant can compell the other side to produce relevant documents. This is possible in the US in product liability trials for every product EXCEPT vaccines. The National Vaccine Injury Compensation Act provides vaccine manufacturers with complete liability immunity and it takes away the right to discovery by anyone injured by a vaccine. There is no chance that these documents would have ever been revealed in the US.
Please read this article about the Italian trial by Mary Holand that was published on the Age of Autism.
http://www.ageofautism.com/2015/01/recent-italian-court-decisions-on-vaccines-and-autism.html Confidential GSK Report p33-47 chartPlease share this message with family and friends and please share on social networks.